期刊名称：ANTI-CANCER DRUGS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
Anti-Cancer Drugs provides oncologists with current information on the clinical and experimental effects of toxic and non-toxic cancer agents, and coverage of breakthroughs in cancer treatment. Among the topics published are cytotoxic chemotherapy, hormonal or biological response modifiers such as interleukins, immunotherapy, drug design, adverse effects of drugs, and drug resistance. Anti-Cancer Drugs places a particularly strong emphasis on papers reporting treatments to alleviate the side-effects of chemotherapy.
- Index Medicus/Medline
- Current Contents/Life Sciences
- Science Citation Index
- SCISEARCH
- Medical Documentation Service
- Research Alert
- Excerpta Medica/EMBASE Chemical Abstracts
- CABS (Current Awareness in Biological Sciences)
- Cambridge Scientific Abstracts
- BIOSIS
- ADONIS (via CD-ROM)
|
|
Instructions to Authors
Note: These instructions comply with those formulated by the International Committee of Medical Journal Editors. For further details, authors should consult the following article: International Committee of Medical Journal Editors. "Uniform requirements for manuscripts submitted to biomedical journals." N Engl J Med 1997; 336: 309–15. The complete document appears at www.icmje.org.
Scope
Anti-Cancer Drugs is devoted to the rapid publication of innovative investigations on therapeutic agents against cancer and methods to diminish adverse effects of drugs. The journal publishes peer reviewed articles on anti-cancer drug design, drug delivery, pharmacology and chemotherapy evaluation.
POINTS TO CONSIDER WHEN SUBMITTING YOUR PAPER TO ONE OF OUR JOURNALS
We have prepared a standard covering letter to accompany your submission. Whether you use this letter or your own wording, please think carefully about the following points and make the appropriate declarations.
Redundant or duplicate publication
We ask you to confirm that your paper has not been published in its current form or a substantially similar form (in print or electronically, including on a web site), that it has not been accepted for publication elsewhere, and that it is not under consideration by another publication. The International Committee of Medical Journal Editors has provided details of what is and what is not duplicate or redundant publication. If you are in doubt (particularly in the case of material that you have posted on a web site), we ask you to proceed with your submission but to include a copy of the relevant previously published work or work under consideration by other journals.
Conflicts of interest
We ask authors to state all possible conflicts of interest, including financial and other relationships. If you are sure that there is no conflict of interest, please state this. Some of our journals will print your statement; others at present do not. You might like to look at an editorial in the British Medical Journal' on Beyond conflict of interest. Remember that sources of funding should be acknowledged in your paper.
Permissions to reproduce previously published material
We ask you to send us copies of permission to reproduce material (such as illustrations) from the copyright holder. We cannot send your paper to press without these permissions!
Patient consent forms
The protection of a patient's right to privacy is essential. We ask you to send copies of patient consent forms on which patients or other subjects of your experiments clearly grant permission for the publication of photographs or other material that might identify them. If the consent form for your research did not specifically include this, please obtain it or remove the identifying material. A sample patient consent form is available here if required.
Ethics committee approval
You must state clearly in your submission in the Methods section that you conducted studies on human participants must with the approval of an appropriate named ethics committee. Please also look at the latest version of the Declaration of Helsinki. Similarly, you must confirm that experiments involving animals adhered to ethical standards and must state the care of animal and licensing guidelines under which the study was performed.
Authorship
We ask that all authors sign the submission letter. First, we have (rarely) had problems when someone named as an author was not aware of the submission of a paper and, on occasion, did not support the findings published. We therefore ask all authors to confirm that they have read and approved the paper. Second, we ask all authors to confirm that they have met the criteria for authorship as established by the International Committee of Medical Journal Editors, believe that the paper represents honest work, and are able to verify the validity of the results reported. You might also be interested to read the debate on authorship in general in the British Medical Journal's Authorship collection.
Many of the points covered above are discussed in the New England Journal of Medicine's collection of papers entitled 'Editorial policies'.
Copyright assignment. Papers are accepted for publication on the understanding that exclusive copyright in the paper is assigned to the Publisher. Authors are asked to sign a copyright assignment form after acceptance of their papers. They may use material from their paper in other works published by them.
Submissions
Submissions, which should include both a printed manuscript and a disk or CD-ROM, should be sent to:
Dr Mels Sluyser, Editor-in-Chief
Anti-Cancer Drugs
The Netherlands Cancer Institute, Plesmanlaan 121,
1066 AC Amsterdam, The Netherlands.
Tel: (+31) 35 52 59 943; Fax: (+31) 20 51 22 029;
E-mail: m.sluyser@planet.nl
Include the following where appropriate: patient consent forms; transfer of copyright form; permission to reproduce previously published material; checklist. Submit the required number of paper copies and keep copies of everything submitted.
Manuscripts should be submitted in quadruplicate (the original plus 3 copies; including the illustrations). Manuscripts should be typed on white bond paper. Margins should be not less than 3 cm. Double spacing should be used throughout the manuscript, which should include the following sections, each starting on a separate sheet: title page, abstract and keywords, text, acknowledgements, references, individual tables and captions. Pages should be numbered consecutively, beginning with the title page, and the page number should be placed in the top right-hand corner of each page. Abbreviations should be defined on their first appearance in the text; those not accepted by international bodies should be avoided.
Disks and CD-ROMS. All submissions should include electronic files using either floppy disks or CD ROMs. Put only the latest version of the manuscript on the disk; name the file clearly; label the disk with the format of the file and the file name; provide information on the hardware and software used. Authors should consult the Electronic Submissions page on the journal's web site for full details of acceptable formats, including electronic artwork.
Authors who wish to submit papers by E-mail should contact the Editorial Office first.
Authors are invited to list up to four potential reviewers, including their full addresses, telephone and fax numbers, and E-mail addresses.
Presentation of papers
Title page. The title page should carry the full title of the paper and a short title to be used as a 憆unning head?(and which should be so identified). The first name, middle initial and last name of each author should appear. If the work is to be attributed to a department or institution, its full name should be included. Any disclaimers should appear on the title page, as should the name, address, telephone and fax numbers, and E-mail address of the author responsible for correspondence concerning the manuscript, and the name and address of the author to whom requests for reprints should be made. Finally, the title page should include the sources of any support for the work in the form of grants, equipment, drugs or any combination of these.
Abstracts. The second page should carry a structured abstract of no more than 250 words. The abstract should state the Objective(s) of the study or investigation, basic Methods (selection of study subjects or laboratory animals; observational and analytical methods), main Results (giving specific data and their statistical significance, if possible) and the principal Conclusions. It should emphasize new and important aspects of the study or observations.
Key words. The abstract should be followed by a list of 3–10 key words or short phrases which will assist the cross- indexing of the article and which may be published. When possible, the terms used should be from the Medical Subject Headings list of the Index Medicus (http://www.nlm.nih.gov/mesh/meshhome.html).
Text. Full papers of an experimental or observational nature may be divided into sections headed Introduction, Methods (including ethical and statistical information), Results and Discussion (including a conclusion), although reviews may require a different format.
Acknowledgments. Acknowledgments should be made only to those who have made a substantial contribution to the study. Authors are responsible for obtaining written permission from people acknowledged by name in case readers infer their endorsement of data and conclusions.
References. References should be numbered consecutively in the order in which they first appear in the text. They should be assigned Arabic numerals, which should be given in brackets, e.g. [17], not superscript. References should include the names of all authors when six or fewer; when seven or more, list only the first six names and add et al. References should also include full title and source information. Journal names should be abbreviated as in the Index Medicus (http://www.medscape.com/Home/Search/Index-Medicus/IndexMedicus.html).
Standard journal article:
Hayakawa S, Kimura T, Saeki K, et al. Apoptosis-inducing activity of high molecular weight fractions of tea extracts. Biosci Biotechnol Biochem 2001; 65: 459–62.
Book:
Banzet P, Holland JF, Khayat D, Weil N. Cancer treatment update. Paris: Springer-Verlag 1994.
Chapter in a book:
Hrushesky WJM, Cope FO. Fluoropyrimidine cancer chemotherapy. In: Banzet P, Holland JF, Khayat D, Weil N, eds. Cancer treatment update. Paris: Springer-Verlag 1994: 29–39.
Personal communications and unpublished work should not feature in the reference list but should appear in parentheses in the text. Unpublished work accepted for publication but not yet released should be included in the reference list with the words `in press' in parentheses beside the name of the journal concerned. References must be verified by the author(s) against the original documents.
Tables. Each table should be typed on a separate sheet in double spacing. Tables should not be submitted as photographs. Each table should be assigned an Arabic numeral, e.g. (Table 3) and a brief title. Vertical rules should not be used. Place explanatory matter in footnotes, not in the heading. Explain in footnotes all non-standard abbreviations that are used in each table. Identify statistical measures of variations, such as standard deviation and standard error of the mean.
Be sure that each table is cited in the text. If you use data from another published or unpublished source, obtain permission and acknowledge the source fully.
Illustrations. References to figures and tables should be made in order of appearance in the text and should be in Arabic numerals in parentheses, e.g. (Figure 2). Notes on the electronic submission of illustrations can be found on the journal's web site. If hard copies are submitted they should have a label pasted to the back bearing the figure number, the title of the paper, the author's name and a mark indicating the top of the figure. Illustrations should not be mounted. Half-tone illustrations should be presented as glossy prints to a width of 80 mm; line illustrations should be presented as original artwork or prints to a width of 80 mm or, when the illustration demands it, to a width of 165 mm. Photomicrographs must have internal scale markers. If photographs of people are used, their identities must be obscured or the picture must be accompanied by written consent to use the photograph. If a figure has been published before, the original source must be acknowledged and written permission from the copyright holder for both print and electronic formats should be submitted with the material. Permission is required regardless of authorship or publisher, except for documents in the public domain. Figures may be reduced, cropped or deleted at the discretion of the Editor. Color illustrations are acceptable but authors will be expected to cover the extra reproduction costs (for current charges, contact the publisher).
Legends for illustrations. Captions should be typed in double spacing, beginning on a separate sheet of paper. Each one should have an Arabic numeral corresponding to the illustration to which it refers. Internal scales should be explained and staining methods for photomicrographs should be identified.
Units of measurement. Measurements of length, height, weight and volume should be reported in metric units (meter, kilogram or liter) or their decimal multiples. Temperatures should be given in degrees Celsius. Blood pressures should be given in millimeters of mercury.
All hematologic and clinical chemistry measurements should be reported in the metric system in terms of the International System of Units (SI). Editors may request that alternative or non-SI units be added by the authors before publication.
Abbreviations and symbols. Use only standard abbreviations. Avoid abbreviations in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.
Offprints
Offprints may be purchased using the appropriate form that will be made available with proofs. Orders should be sent when the proofs are returned; orders received after this time cannot be fulfilled.
/**/
Editorial Board
|
EDITOR
Mels Sluyser, PhD
The Netherlands Cancer Institute
Plesmanlaan 121
1066 CX Amsterdam
The Netherlands
Tel: (+31) 35 52 59 943
Fax: (+31) 20 51 22 029
E-mail: msluys@nki.nl
|
EDITORIAL BOARD
|
D. S. Alberts
Tucson, AZ, USA
C. J. Allegra
Bethesda, MD, USA
M. Al-Sarraf
Southfield, MI, USA
R. F. Asbury
Rochester, NY, USA
J. Beijnen
Amsterdam, The Netherlands
R. A. Bender
San Diego, CA, USA
P. Bey
Nancy, France
H. Bleiberg
Brussels, Belgium
G. Bonadonna
Milan, Italy
H. W. Br點kner
New York, NY, USA
D. Catovsky
London, UK
H. Cort閟-Funes
Madrid, Spain
I. A. Cree
London, UK
W.S Dalton
Tampa, FL, USA
PH.M. De Mulder
Nijmegen, The Netherlands
M. D'Incalci
Milan, Italy |
牋 |
L. H. Einhorn
Indianapolis, IN, USA
G. Eisenbrand
Kaiserslautern, Germany
H. H. Fiebig
Freiburg, Germany
A. Fulton
Baltimore, MD, USA
A. Gabizon
Jerusalem, Israel
D.R. Gandara
Sacremento, CA, USA
A. L. Harris
Oxford, UK
B. T. Hill
Castres, France
A. L. Jones
London, UK
S. B. Kaye
Glasgow, UK
D. Khayat
Paris, France
D. T. Kiang
Minneapolis, MN, USA
E. S. Kleinerman
Houston, TX, USA
C. Kurbacher
Cologne, Germany
V. Ling
Vancouver, Canada
A. Manetta
Orange, CA, USA |
牋 |
D. Maraninchi
Marseille, France
J. A. Merritt
San Diego, CA, USA
F. M. Muggia
New York, NY, USA
C. E. Myers
Charlottesville, VA, USA
M. O'Brian
Sutton, UK
R. F. Ozols
Philadelphia, PA, USA
C. Sartori
Hamburg, Germany
E.A. Sausville
Bethesda, MD, USA
L.W. Seymour
Birmingham, UK
M.B. Sporn
Hanover, NH, USA
Y. Une
Sapporo, Japan
A. T. van Oosterom
Leuven, Belgium
F.A. Valeriole
Detroit, MI, USA
D.R. Welch
Hershey, PA, USA
G. Zon
Hayward, CA, USA |
|
刊名字顺( Alphabetical List of Journals):
返回页首 